Antibiotics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 – 2030

The Global Antibiotics Market Size accounted for USD 42 Billion in 2021 and is estimated to garner a market size of USD 63 Billion by 2030 rising at a CAGR of 4.6% from 2022 to 2030. Antibiotics are medicines that help in fighting against bacterial infection in humans as well as animals. They kill the bacteria or prevent them from growing and multiplying in the host. Additionally, the antibiotics can be taken in different ways that include orally, topically, or intravenously according to the requirement of the person or the intensity of the infection. Advent of novel approaches for new antibiotics is a popular antibiotics market trend that is pushing the industry growth forward.

Antibiotics Market Report Key Highlights

• Global antibiotics market revenue is estimated to reach USD 63 Billion by 2030 with a CAGR of 4.6% from 2022 to 2030
• Asia-Pacific antibiotics market share accounted for over 45% regional shares in 2021
• According to the University of Oxford, global antibiotic consumption rates increased by 46% between 2000 and 2018
• Asia-Pacific antibiotics market growth will record fastest CAGR from 2022 to 2030
• Based on product type segment, penicillin accounted 28% of the overall market share in 2021
• Growing prevalence of chronic disorders propels the antibiotics market value in coming years

Global Antibiotics Market Dynamics

Market Drivers

• Rising incidence of infectious diseases
• Increasing development of advanced products
• Advent of novel approaches for new antibiotics

Market Restraints

• Development of resistance against antibiotics
• High research & development cost

Market Opportunities

• Surplus R&D activities to develop advanced combination therapies
• Discovery of advanced prospect molecules

Antibiotics Market Report Coverage

Market Dynamics

The development of advanced products by the major manufacturers along with the increasing infectious diseases burden is driving the market growth.

The increasing prevalence of infectious diseases such as lower respiratory infections, malaria, pneumonia, and tuberculosis are supporting the demand in the global market. The growing number of collaborations for the development of antibiotics among the major players is additionally bolstering the market value. The government and non-government bodies are increasing their investment budget in R&D initiatives and to boost the development of novel antibiotics and supportive regulatory policies due to increasing disease burden is further bolstering the market growth. Furthermore, the discovery of advanced prospect molecules, as well as the introduction of novel combination therapies to treat antibiotic-resistant microbial infections, is likely to create potential opportunities over the forecast period.

On the other side, high R&D cost and development of resistance against antibiotics are the factors likely to limit the growth to an extent during the estimated period.

Antibiotics Market Segmentation

The worldwide antibiotics market is split based on product type, drug origin, spectrum, route of administration, distribution channel, and geography.

Antibiotics Market By Product Type

• Cephalosporins
• Penicillin
• Fluoroquinolones
• Macrolides
• Carbapenems
• Aminoglycosides
• Sulfonamides
• Other Product Types

Based on product type, the penicillin sub-segment achieved a significant share in 2021 and is expected to do so in the coming years from 2022 to 2030. The high growth in the segment is credited to the highest prescription and most number of generic manufacturers in the space.

Antibiotics Market By Drug Origin

• Natural
• Semi-Synthetic
• Synthetic

According to our antibiotics industry analysis, the natural drug origin is anticipated to grow with a substantial rate from 2022 to 2030. On the other hand, synthetic and semi-synthetic are holding significant market share owing to easy availability.

Antibiotics Market By Spectrum

• Broad-Spectrum Antibiotic
• Narrow-Spectrum Antibiotic

On the basis of spectrum, the broad-spectrum antibiotic is the leading segment in the global antibiotics market. These are active against a wider number of bacterial types and, thus have a demand for the treatment of a variety of infectious diseases. These are mostly used when the bacterial infection is suspected but the group of bacteria is unknown or in the case when infection with multiple groups of bacteria is suspected. The ability to treat a wider range of bacterial infections is primarily bolstering the segmental market value

Antibiotics Market By Route of Administration

• Oral
• Intravenous
• Others

In 2021, oral route of administration generated utmost market revenue and is expected to continue its trend during the forecast timeframe from 2022 to 2030. The easy availability and tremendous growth in oral prescription are some of the factors that are fueling the segmental growth.

Antibiotics Market By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others

According to our antibiotics market forecast, retail pharmacy and hospital pharmacy are the major revenue generating segment in 2021. However, due to the trend of online shopping and increased e-commerce websites the online pharmacy sub-segment is likely to register the fastest growth rate from 2022 to 2030.

Antibiotics Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa

Growth in Prevalence of Chronic Disorders Fuels the North America Antibiotics Market Share

Based on regions, North America leads the Antibiotics market. Growing healthcare sectors result in the adoption of diagnostic kits to detect various infectious diseases caused due to bacteria and viruses. On the other hand, Asia-Pacific is expected to witness the highest growth rate for the Antibiotics market owing to surging awareness among the healthcare sectors and ever-growing patient population about the rapid medical diagnostic tools.

Antibiotics Market Players

The global antibiotics companies profiled in the report include Abbott Laboratories, Allergan plc, Basilea Pharmaceutica Ltd., Bayer Healthcare AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Inc., Melinta Therapeutics, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Tetraphase Pharmaceuticals.